Sangui Biotech International (OTCMKTS:SGBI) Shares Down 62.4%

Sangui Biotech International, Inc. (OTCMKTS:SGBI)’s stock price fell 62.4% on Monday . The stock traded as low as $0.01 and last traded at $0.01, 20,000 shares traded hands during trading. An increase of 33% from the average session volume of 15,000 shares. The stock had previously closed at $0.03.

The company has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.02.

About Sangui Biotech International (OTCMKTS:SGBI)

Sangui Biotech International, Inc, through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds.

Read More: What is a Buy-Side Analyst?

Receive News & Ratings for Sangui Biotech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sangui Biotech International and related companies with MarketBeat.com's FREE daily email newsletter.